Axel Backheuer

Qiagen AG manufactures biological products for purification, transfection, and amplification of nucleic acid and proteins. The company was founded on September 15, 1994 and is headquartered in Basel, Switzerland.

Exiqon A/S engages in the development of solutions for ribonucleic acid research and analysis through its Locked Nucleic Acid proprietary technology. Its products and services are used by researchers in academia, biotech, and pharmaceutical companies around the world to make discoveries about the correlation between gene activity and the development of disease. The company was founded by Mikael Ørum, Henrik Ørum and Troels Koch on November 1, 1995 and is headquartered in Copenhagen, Denmark.

QIAGEN Instruments AG engages in the development, production, and distribution of analytical instruments and devices. It also acquires participating interests in firms, as well as acquires and utilizes patents, licenses, and other rights. The company was founded on February 28, 1990 and is headquartered in Hombrechtikon, Switzerland.

Qiagen Healthcare Biotechnologies Systems Ltd. engages in the activities related to maintaining of intangible assets. It involves in the production of products which allow to collect, stabilze and archive DNA and blood related to the forensics life science Business. The company was founded on September 10, 2018 and is headquartered in Manchester, The United Kingdom.

QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark.